Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V. M Srivastava
Impact of FLT3 Mutations and Secondary Cytogenetic Changes on the Outcome of Patients With Newly Diagnosed Acute Promyelocytic Leukemia Treated With a Single Agent Arsenic Trioxide Regimen
Haematologica
Hematology
Related publications
Clinical Outcome of Patients With Acute Promyelocytic Leukemia and FLT3 Mutations
American Journal of Hematology
Hematology
Impact of Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Pseudotumor Cerebri After Treatment of Relapsed Acute Promyelocytic Leukemia With Arsenic Trioxide
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Acute-Onset Hypokalemic Paralysis With Arsenic Trioxide Therapy in Patient With Acute Promyelocytic Leukemia
Journal of Community and Supportive Oncology
Oncology
Hematology
Arsenic Trioxide-Based Therapy Is Suitable for Patients With Psoriasis-Associated Acute Promyelocytic Leukemia – A Retrospective Clinical Study
Hematology
Hematology
Retinoic Acid and Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia: Current Perspectives
OncoTargets and Therapy
Oncology
Pharmacology
Dexamethasone Suppresses Long QT Phenotype in Patient With Acute Promyelocytic Leukemia Treated With Arsenic
HeartRhythm Case Reports
Cardiovascular Medicine
Cardiology
‘Retinoic Acid and Arsenic Trioxide Sensitize Acute Promyelocytic Leukemia Cells to ER Stress’
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
FLT3-ITD Confers Poor Prognosis in Patients With Acute Promyelocytic Leukemia Treated With AIDA Protocols: Long-Term Follow-Up Analysis
Haematologica
Hematology
